 |
|
| DIAGNOSTIC ATLAS OF GASTROESOPHAGEAL REFLUX DISEASE
| |
| | |
|
|
A New Histology-based Method
To order this title, and for more information, click here
By
Parakrama Chandrasoma, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
Description
Gastroesophageal reflux is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from
significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market.
The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac)
and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux.
Unfortunately,
this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare,
reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is
now the most rapidly increasing cancer type in the Western world.
At present, there is no histologic test that has any practical value
in the diagnosis of reflux disease. The only histologic diagnostic criteria are related to changes in the squamous epithelium which are
too insensitive and nonspecific for effective patient management. It is widely recognized that columnar metaplasia of the esophagus (manifest
histologically as cardiac, oxyntocardiac and intestinal epithelia) is caused by reflux. However, except for intestinal metaplasia, which
is diagnostic for Barrett esophagus, these columnar epithelia are not used to diagnose reflux disease in biopsies. The reason for this
is that these epithelial types are indistinguishable from "normal" "gastric" cardiac mucosa. In standard histology texts, this "normal
gastric cardia" is 2-3 cm long.
In the mid-1990s, Dr. Chandrasoma and his team at USC produced autopsy data suggesting that cardiac
and oxyntocardiac mucosa is normally absent from this region and that their presence in biopsies was histologic evidence of reflux disease.
From this data, they determined that the presence of cardiac mucosa was a pathologic entity caused by reflux and could therefore be used
as a highly specific and sensitive diagnostic criterion for the histologic diagnosis of reflux disease. They call this entity "reflux
carditis". In addition, the length of these metaplastic columnar epithelia in the esophagus was an accurate measure of the severity of
reflux disease in a given patient.
At present, there is some controversy over whether cardiac mucosa is totally absent or present normally
to the extent of 0-4 mm. While this should not be a deterrent to changing criteria which are dependent on there normally being 20-30
cm of cardiac mucosa, there has been little mainstream attempt to change existing endoscopic and pathologic diagnostic criteria in the
mainstream of either gastroenterology or pathology.
The ATLAS will be the source of easily digestible practical information for pathologists
faced with biopsies from this region. It will also guide gastroenterologists as they biopsy these patients.
Audience
Practicing pathologists and gastroenterologists; graduate students, medical students and researchers in pathology, gastroenterology, histology, and anatomy.
Contents
OVERVIEW
The need for change in diagnostic criteria – changes in the concept of normalcy in the gastroesophageal junction in the past
decade.
Present controversy
Biopsy protocols – present and future
HISTOLOGIC DEFINITION OF EPITHELIAL TYPES
CHANGES IN SQUAMOUS EPITHELIUM
IN GERD
COLUMNAR METAPLASIA OF ESOPHAGUS – TYPES
The evolution of cardiac mucosa and its significance
Classification of the population
and grading
Quantitating intestinal metaplasia
REFLUX CARDITIS
BARRETT (INTESTINAL) METAPLASIA
CASE STUDIES
Normal patient
Compensated
reflux
Minimal reflux disease
Moderate reflux disease
Severe reflux disease
Microscopic Barrett esophagus
Short segment Barrett esophagus
Long segment Barrett esophagus
DIFFERENTIAL DIAGNOSTIC PROBLEMS
Patient with accompanying gastritis
Patient with atrophic gastritis and
gastric intestinal metaplasia
CK7, CK20
Mucin histochemistry
DYSPLASIA AND ADENOCARCINOMA
| Bibliographic details |
Hardbound, 320 pages, publication date: JUL-2007
ISBN-13: 978-0-12-373605-5
ISBN-10: 0-12-373605-6
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 99
USD 160
EUR 116.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/925
Last update: 5 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company